• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VBS
Click for more information
0.00% 8.0¢

VECTUS BIOSYSTEMS LIMITED - Announcements

Market Cap $4.256M  ! watchlist Created with Sketch. Add to my watchlist

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
VBS Half Year Report and Appendix 4DPRICE SENSITIVE28/02/19
VBS Response to ASX Appendix 4C QueryPRICE SENSITIVE22/02/19
VBS Appendix 4C - Quarterly ReportPRICE SENSITIVE31/01/19
VBS CEO's Address to ShareholdersPRICE SENSITIVE14/11/18
VBS Chairman's Address to ShareholdersPRICE SENSITIVE14/11/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/10/18
VBS Preliminary Final ReportPRICE SENSITIVE31/08/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
VBS Half Year Report and Appendix 4DPRICE SENSITIVE28/02/18
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
VBS Appendix 4C - QuarterlyPRICE SENSITIVE31/10/17
VBS Successful Pre-Clinical Trial and Granting of Key PatentPRICE SENSITIVE20/10/17
VBS Preliminary Final ReportPRICE SENSITIVE31/08/17
VBS Appendix 4C - quarterlyPRICE SENSITIVE31/07/17
VBS Appendix 4C - Quarterly Report and UpdatePRICE SENSITIVE28/04/17
VBS Half Yearly Report and Appendix 4DPRICE SENSITIVE28/02/17
VBS Response to ASX Appendix 4C QueryPRICE SENSITIVE13/02/17
VBS Appendix 4C - quarterlyPRICE SENSITIVE30/01/17
VBS Response to ASX Appendix 4C QueryPRICE SENSITIVE14/11/16
VBS Appendix 4C - quarterly-VBS.AX PRICE SENSITIVE31/10/16
VBS Preliminary Final Report-VBS.AX PRICE SENSITIVE31/08/16
VBS Appendix 4C - quarterly-VBS.AX PRICE SENSITIVE29/07/16
VBS Appendix 4C - quarterly-VBS.AX PRICE SENSITIVE29/04/16
VBS Scientific Paper on Accugen TechnologyPRICE SENSITIVE15/03/16
VBS Key Accugen Patent Granted in USAPRICE SENSITIVE07/03/16
VBS Admission to Official ListPRICE SENSITIVE22/02/16
VBS Half Year Report and Appendix 4D
28/02/19PRICE SENSITIVE
VBS Response to ASX Appendix 4C Query
22/02/19PRICE SENSITIVE
VBS Appendix 4C - Quarterly Report
31/01/19PRICE SENSITIVE
VBS CEO's Address to Shareholders
14/11/18PRICE SENSITIVE
VBS Chairman's Address to Shareholders
14/11/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/10/18PRICE SENSITIVE
VBS Preliminary Final Report
31/08/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
VBS Half Year Report and Appendix 4D
28/02/18PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
VBS Appendix 4C - Quarterly
31/10/17PRICE SENSITIVE
VBS Successful Pre-Clinical Trial and Granting of Key Patent
20/10/17PRICE SENSITIVE
VBS Preliminary Final Report
31/08/17PRICE SENSITIVE
VBS Appendix 4C - quarterly
31/07/17PRICE SENSITIVE
VBS Appendix 4C - Quarterly Report and Update
28/04/17PRICE SENSITIVE
VBS Half Yearly Report and Appendix 4D
28/02/17PRICE SENSITIVE
VBS Response to ASX Appendix 4C Query
13/02/17PRICE SENSITIVE
VBS Appendix 4C - quarterly
30/01/17PRICE SENSITIVE
VBS Response to ASX Appendix 4C Query
14/11/16PRICE SENSITIVE
VBS Appendix 4C - quarterly-VBS.AX
31/10/16PRICE SENSITIVE
VBS Preliminary Final Report-VBS.AX
31/08/16PRICE SENSITIVE
VBS Appendix 4C - quarterly-VBS.AX
29/07/16PRICE SENSITIVE
VBS Appendix 4C - quarterly-VBS.AX
29/04/16PRICE SENSITIVE
VBS Scientific Paper on Accugen Technology
15/03/16PRICE SENSITIVE
VBS Key Accugen Patent Granted in USA
07/03/16PRICE SENSITIVE
VBS Admission to Official List
22/02/16PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
VBS (ASX) Chart

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Palladium's the newest geopolitical hot commodity. But ASX exposure is limited On October 24, the USA reportedly approached its G7 counterparts and proposed a ban on Russian titanium, and, palladium.
Bitcoin jumps 8% to beat record on Trump vote optimism Bitcoin has been a big winner on financial markets today, tracking Donald Trump's election highs with an 8% rise and beating a previous record
Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits Nanocap Si6 Metals (ASX:SI6) is on the cusp of kicking off drilling at its Monument project in WA, sniffing after historical gold hit targets.
Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62% Lor Resources Ltd has entered into a binding earn-in agreement with Blackrock Resources Pty Ltd to take on up to 80% of the Ilgarari project
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.